Abstract
A human‐leukocyte‐derived antiviral protein (22‐kDa factor), known to be an inducer of interferon‐β (IFN‐β) in fibroblastoid cells, and to be closely related to interleukin‐1 (IL‐1), was shown to likewise act as inducer of the mRNA of a 26‐kDa secreted protein. This protein was first described as the gene product of an mRNA that is co‐induced with the mRNA of IFN‐β by superinduction of fibroblasts (treatment with dsRNA and cycloheximide). Subsequently it was shown to be induced by treatment with cycloheximide only. The 22‐kDa factor induced high levels of the 26‐kDa‐protein mRNA and low levels of IFN‐β mRNA. Addition of cycloheximide to the 22‐kDa‐factor resulted in further significant increases in mRNA levels for both the 26‐kDa‐protein and IFN‐β. These observations add to the evidence already available that transcription of the genes for IFN‐β and the 26‐kDa‐protein are differently regulated. The observation that a factor that belongs to the IL‐1 family induces the 26‐kDa‐protein suggest that the latter plays a role as an intermediary or effector molecule in inflammatory or immunoregulatory processes. Copyright © 1985, Wiley Blackwell. All rights reserved
Cite
CITATION STYLE
CONTENT, J., DE WIT, L., POUPART, P., OPDENAKKER, G., VAN DAMME, J., & BILLIAU, A. (1985). Induction of a 26‐kDa‐protein mRNA in human cells treated with an interleukin‐1‐related, leukocyte‐derived factor. European Journal of Biochemistry, 152(2), 253–257. https://doi.org/10.1111/j.1432-1033.1985.tb09191.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.